Topical, transdermal, and long-acting injectables are moving fast, and expectations for purity, performance, and regulatory readiness are higher than ever.
Ventyx is developing a pipeline of small molecule therapeutics designed to treat inflammation across a broad range of disease states with high unmet need.
Sino Biological is a leading global CRO with 18+ years’ expertise in protein production and antibody development. Our proprietary recombinant production platforms enable efficient HTP expression to kg-scale manufacturing. We offer integrated services from antibody discovery to engineering and production, accelerating your path from bench to clinic.
Abzena is the leading end-to-end bioconjugate (ADC, AOC, & RDC) & complex biologics CDMO + CRO. From discovery through commercial, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development and manufacture of new treatments for patients. Let us help move your program forward faster.
